Charles Schwab
HOLX

Charles Schwab’s Hologic HOLX Stock Holding History

Charles Schwab’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,157,358
Closed -$163M – 3491
2026
Q1 		$163M Buy
2,157,358
+61,396
+3% +$4.62M 0.02% 498
2025
Q4 		$156M Buy
2,095,962
+28,671
+1% +$2.09M 0.02% 514
2025
Q3 		$140M Buy
2,067,291
+624,299
+43% +$41.4M 0.02% 545
2025
Q2 		$94M Buy
1,442,992
+288
+0% +$17.3K 0.02% 705
2025
Q1 		$89.1M Sell
1,442,704
-29,145
-2% -$1.93M 0.02% 708
2024
Q4 		$106M Sell
1,471,849
-55,252
-4% -$4.32M 0.02% 630
2024
Q3 		$124M Sell
1,527,101
-15,524
-1% -$1.24M 0.02% 544
2024
Q2 		$115M Buy
1,542,625
+82,302
+6% +$6.17M 0.02% 576
2024
Q1 		$114M Buy
1,460,323
+13,555
+0.9% +$1.01M 0.03% 543
2023
Q4 		$103M Buy
1,446,768
+26,730
+2% +$1.86M 0.03% 543
2023
Q3 		$98.6M Sell
1,420,038
-3,145
-0.2% -$238K 0.03% 507
2023
Q2 		$115M Buy
1,423,183
+26,144
+2% +$2.14M 0.03% 461
2023
Q1 		$113M Buy
1,397,039
+3,465
+0.2% +$279K 0.03% 456
2022
Q4 		$104M Buy
1,393,574
+52,260
+4% +$3.72M 0.03% 462
2022
Q3 		$86.5M Buy
1,341,314
+6,919
+0.5% +$479K 0.03% 491
2022
Q2 		$92.5M Buy
1,334,395
+28,422
+2% +$2.11M 0.03% 477
2022
Q1 		$100M Buy
1,305,973
+62,457
+5% +$4.49M 0.03% 516
2021
Q4 		$95.2M Buy
1,243,516
+589
+0% +$43.3K 0.03% 549
2021
Q3 		$91.7M Sell
1,242,927
-79,442
-6% -$5.96M 0.03% 533
2021
Q2 		$88.2M Sell
1,322,369
-51,970
-4% -$3.47M 0.03% 552
2021
Q1 		$102M Sell
1,374,339
-133,272
-9% -$10.1M 0.04% 446
2020
Q4 		$110M Sell
1,507,611
-106,037
-7% -$7.49M 0.04% 380
2020
Q3 		$107M Buy
1,613,648
+70,309
+5% +$4.45M 0.05% 341
2020
Q2 		$88M Sell
1,543,339
-453,480
-23% -$22.3M 0.04% 396
2020
Q1 		$70.1M Buy
1,996,819
+18,679
+0.9% +$889K 0.04% 401
2019
Q4 		$103M Buy
1,978,140
+59,304
+3% +$2.95M 0.06% 315
2019
Q3 		$96.9M Sell
1,918,836
-41,738
-2% -$2.05M 0.06% 308
2019
Q2 		$94.1M Buy
1,960,574
+363,053
+23% +$16.8M 0.06% 321
2019
Q1 		$77.3M Sell
1,597,521
-448,136
-22% -$20.2M 0.05% 362
2018
Q4 		$84.1M Buy
2,045,657
+283,739
+16% +$11.6M 0.06% 276
2018
Q3 		$72.2M Buy
1,761,918
+559,763
+47% +$22.6M 0.05% 370
2018
Q2 		$47.8M Buy
1,202,155
+74,861
+7% +$2.88M 0.03% 521
2018
Q1 		$42.1M Buy
1,127,294
+74,771
+7% +$3.02M 0.03% 559
2017
Q4 		$45M Buy
1,052,523
+38,522
+4% +$1.54M 0.04% 502
2017
Q3 		$37.2M Buy
1,014,001
+47,109
+5% +$1.9M 0.03% 540
2017
Q2 		$43.9M Sell
966,892
-1,020,325
-51% -$45M 0.04% 447
2017
Q1 		$84.6M Sell
1,987,217
-462,869
-19% -$18.9M 0.08% 230
2016
Q4 		$98.3M Sell
2,450,086
-138,386
-5% -$5.34M 0.11% 181
2016
Q3 		$100M Sell
2,588,472
-25,741
-1% -$972K 0.12% 160
2016
Q2 		$90.6M Sell
2,614,213
-64,684
-2% -$2.24M 0.11% 171
2016
Q1 		$92.4M Buy
2,678,897
+722,836
+37% +$25.2M 0.12% 160
2015
Q4 		$75.7M Buy
1,956,061
+718,741
+58% +$28M 0.1% 184
2015
Q3 		$48.4M Buy
1,237,320
+39,373
+3% +$1.56M 0.07% 268
2015
Q2 		$45.6M Buy
1,197,947
+333,970
+39% +$11.7M 0.06% 299
2015
Q1 		$28.5M Buy
863,977
+76,364
+10% +$2.34M 0.04% 441
2014
Q4 		$21.1M Buy
787,613
+305,840
+63% +$7.89M 0.03% 508
2014
Q3 		$11.7M Sell
481,773
-13,867
-3% -$350K 0.02% 698
2014
Q2 		$12.6M Buy
495,640
+30,240
+6% +$707K 0.02% 671
2014
Q1 		$10M Buy
465,400
+53,803
+13% +$1.16M 0.02% 797
2013
Q4 		$9.2M Sell
411,597
-17,718
-4% -$391K 0.02% 780
2013
Q3 		$8.95M Buy
429,315
+83,047
+24% +$1.77M 0.02% 715
2013
Q2 		$6.78M Buy
+346,268
New +$7.23M 0.02% 799

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Charles Schwab's HOLX Position: Q2 2026 in Review

Charles Schwab sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,157,358 shares — an estimated $163M sold.

Charles Schwab first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $163M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Charles Schwab reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Charles Schwab sold 2,157,358 Hologic shares in Q2 2026, an estimated $163M.
  • Charles Schwab first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
  • Charles Schwab's Hologic position peaked at $163M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.